Company

Jeil Pharmaceutical Co.,Ltd

Headquarters: Seoul, South Korea

Employees: 949

KRX: 271980 -1.63%

Market Cap

₩168.01 Billion

KRW as of Jan. 1, 2025

US$114.3 Million

Market Cap History

Jeil Pharmaceutical Co.,Ltd Categories

South Korea Healthcare Drug Manufacturers—Specialty & Generic
South Korea Healthcare South Korea Drug Manufacturers—Specialty & Generic

Jeil Pharmaceutical Co.,Ltd market capitalization over time

Evolution of Jeil Pharmaceutical Co.,Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Jeil Pharmaceutical Co.,Ltd

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $75.33 B
MERCK Kommanditgesellschaft auf Aktien $65.17 B
Haleon plc $42.16 B
Takeda Pharmaceutical Company Limited $41.47 B
Teva Pharmaceutical Industries Limited $18.95 B
Sector:
Company Market Cap (USD)
Lilly $689.42 B
Novo Nordisk $622.07 B
UnitedHealth Group $487.54 B
Johnson & Johnson $353.05 B
AbbVie $301.60 B

Detailed Description

Jeil Pharmaceutical Co.,Ltd develops and supplies pharmaceutical products primarily in South Korea. It provides products in the areas of antibiotic, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamine. The company also exports its products to approximately 40 countries in ASEAN, Central and South America, Africa, and internationally. Jeil Pharmaceutical Co.,Ltd was founded in 1959 and is headquartered in Seoul, South Korea.

Stocks & Indices

Jeil Pharmaceutical Co.,Ltd has the following listings and related stock indices.


Stock: KRX: 271980 wb_incandescent

Details

Headquarters:

343, Sapyeong-daero

Seocho-gu

Seoul, 06543

South Korea

Phone: 82 2 549 7451

Fax: 82 2 549 4045